Cure of chronic viral infection by neutralizing antibody treatment

Autoimmunity Reviews

Volumn 6, Issue 5, 2007, Pages 267-271

  Ejrnaes, Mette ^a   von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoimmunity; Chronic infection; Immune regulation; LCMV

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD3 ANTIBODY; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; PROINSULIN; PROTEINASE INHIBITOR; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; CHRONIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; REVIEW; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; ANTIBODIES; CHRONIC DISEASE; HUMANS; INTERLEUKIN-10; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; VIRAL LOAD; VIRUS DISEASES;

EID: 33947713875     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.09.002     Document Type: Review

References (40)

1. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146 (1991) 3444
2. O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2 (1990) 821
3. Ding L., Linsley P.S., Huang L.Y., Germain R.N., and Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151 (1993) 1224
4. Willems F., Marchant A., Delville J.P., Gerard C., Delvaux A., Velu T., et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24 (1994) 1007
5. Jinquan T., Larsen C.G., Gesser B., Matsushima K., and Thestrup-Pedersen K. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 151 (1993) 4545
6. Kasama T., Strieter R.M., Lukacs N.W., Burdick M.D., and Kunkel S.L. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 152 (1994) 3559
7. Sozzani S., Ghezzi S., Iannolo G., Luini W., Borsatti A., Polentarutti N., et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187 (1998) 439
8. Takayama T., Morelli A.E., Onai N., Hirao M., Matsushima K., Tahara H., et al. Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol 166 (2001) 7136
9. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., and Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22 (2004) 929
10. Mocellin S., Ohnmacht G.A., Wang E., and Marincola F.M. Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness. Int J Cancer 93 (2001) 236
11. Vicari A.P., and Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth?. Immunol Rev 202 (2004) 223
12. Vicari A.P., Chiodoni C., Vaure C., Ait-Yahia S., Dercamp C., Matsos F., et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med 196 (2002) 541
13. Granelli-Piperno A., Golebiowska A., Trumpfheller C., Siegal F.P., and Steinman R.M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A 101 (2004) 7669
14. Rigopoulou E.I., Abbott W.G., Haigh P., and Naoumov N.V. Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin Immunol 117 (2005) 57
15. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963
16. Ameglio F., Cordiali Fei P., Solmone M., Bonifati C., Prignano G., Giglio A., et al. Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 8 (1994) 48
17. Ji J., Sahu G.K., Braciale V.L., and Cloyd M.W. HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int Immunol 17 (2005) 729
18. Autran B., Legac E., Blanc C., and Debre P. A Th0/Th2-like function of CD4+CD7-T helper cells from normal donors and HIV-infected patients. J Immunol 154 (1995) 1408
19. Akridge R.E., Oyafuso L.K., and Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 153 (1994) 5782
20. Zinkernagel R.M., and Doherty P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248 (1974) 701
21. Marker O., and Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med 137 (1973) 1511
22. Moskophidis D., Assmann-Wischer U., Simon M.M., and Lehmann-Grube F. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur J Immunol 17 (1987) 937
23. Moskophidis D., Lechner F., Pircher H., and Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362 (1993) 758
24. Lin M.Y., and Welsh R.M. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J Exp Med 188 (1998) 1993
25. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282 (1998) 2079
26. Smelt S.C., Borrow P., Kunz S., Cao W., Tishon A., Lewicki H., et al. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alphadystroglycan correlate with viral tropism and disease kinetics. J Virol 75 (2001) 448
27. Borrow P., Evans C.F., and Oldstone M.B. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 69 (1995) 1059
28. Sevilla N., McGavern D.B., Teng C., Kunz S., and Oldstone M.B. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest 113 (2004) 737
29. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853
30. Torriani F.J., Rodriguez-Torres M., Rockstroh J.K., Lissen E., Gonzalez-Garcia J., Lazzarin A., et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351 (2004) 438
31. Kamar N., Boulestin A., Selves J., Esposito L., Sandres-Saune K., Stebenet M., et al. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C. J Med Virol 76 (2005) 61
32. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55 (2003) 241
33. Bresson D., Togher L., Rodrigo E., Chen Y., Bluestone J.A., Herold K.C., et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116 (2006) 1371
34. Ejrnaes M., von Herrath M.G., and Christen U. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies. Clin Dev Immunol 13 (2006) 67
35. Liu Y.J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106 (2001) 259
36. Buelens C., Willems F., Delvaux A., Pierard G., Delville J.P., Velu T., et al. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25 (1995) 2668
37. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145
38. Maldonado-Lopez R., De Smedt T., Michel P., Godfroid J., Pajak B., Heirman C., et al. CD8alpha+ and CD8alpha-subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189 (1999) 587
39. Maldonado-Lopez R., Maliszewski C., Urbain J., and Moser M. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167 (2001) 4345
40. Re F., and Strominger J.L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 12 (2004) 7548